Needham, MA, United States of America

Peng Yi

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Joslin Diabetes Center, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peng Yi. Retrieved from https://idiyas.com/inventor/peng-yi-j7ahiqw7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peng Yi in Diabetes Treatment

Introduction

Peng Yi is an accomplished inventor based in Needham, MA (US). He has made significant contributions to the field of diabetes research, particularly in the protection of beta cells from immune attack. His work is crucial for advancing treatment options for individuals suffering from type 1 diabetes.

Latest Patents

Peng Yi holds a patent for the "Protection of beta cells from immune attack." This patent encompasses compositions of genetically modified beta-like cells. Additionally, it includes methods of treatment for type 1 diabetes using these compositions or compositions that inhibit the function of the identified genes. He has 1 patent to his name, showcasing his innovative approach to tackling this challenging medical condition.

Career Highlights

Peng Yi is affiliated with the Joslin Diabetes Center, Inc., where he continues to work on groundbreaking research. His role at this prestigious institution allows him to collaborate with other experts in the field and contribute to advancements in diabetes treatment.

Collaborations

One of his notable coworkers is Stephan Kissler. Together, they work towards innovative solutions that can improve the lives of those affected by diabetes.

Conclusion

Peng Yi's contributions to diabetes research and his innovative patent highlight his commitment to improving treatment options for type 1 diabetes. His work at the Joslin Diabetes Center, Inc. positions him as a key figure in the ongoing fight against this disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…